Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
Submitted by
admin
on July 26, 2017 - 9:52am
Source:
Endpoints
News Tags:
GSK
reorganization
Emma Walmsley
Pharma CEOs
R&D
cancer
Headline:
GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
Do Not Allow Advertisers to Use My Personal information
